EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Imbalance in WNT: retinoic acid signaling dysregulates HOX gene expression: implications for cancer stem cell heterogeneity and CRC patient survival

Brian Osmond iD, Chi Zhang iD, Pascal K Kataboh, Caroline O B Facey, Lynn M Opdenaker, Bruce M Boman iD

Stem Cells Translational Medicine · 18.05.2026 · 15 (6)

DOI: 10.1093/stcltm/szag043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 26.05.2026. Verfasst von Brian Osmond und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Newark, DE 19713, United States. Hauptthemen laut MEDLINE: Tretinoin, Neoplastic Stem Cells, Colorectal Neoplasms, Wnt Signaling Pathway. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Lisa Dean Moseley Foundation, Cancer B*Ware Foundation, The Cawley Center for Translational Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

How HOX transcription factors play a role in the stem cell (SC) origin of cancer is unclear. Our goal is to determine how dysregulation of HOX gene expression promotes colorectal cancer (CRC) development through aberrant SC regulatory mechanisms. We investigated retinoic acid (RA) and WNT signaling because they regulate HOX expression and both pathways are dysregulated in cancer. Previously, we reported WNT and RA pathways are functionally linked, and in CRC, APC mutation generates a WNT:RA imbalance leading to incomplete differentiation and SC overpopulation. We hypothesize that aberrant WNT- and RA-signaling dysregulates HOX expression that contributes to the SC origin of CRC. We discovered a HOX expression signature of eight genes (six-upregulated, two-downregulated) that are significantly altered in CRC, and that predict poor CRC patient survival. NanoString profiling of fluorescence activated cell sorted SC subpopulations, bioinformatics studies, and RNA-seq analysis of fresh colon tissues revealed: (1). The six-upregulated genes are regulated by RA signaling; (2). ATRA-treatment of CRC cells, but not wt-APC induction or RARA knockout, leads to a HOX expression pattern matching the HOX signature; (3). Mid-cluster (group 3) HOXB gene expression characterizes normal colon, but increased group 3 HOXC expression occurs in CRC; (4). LGR5+ SCs selectively express group 3 HOXB genes while ALDH+ SCs express group 3 HOXC genes; (5). HOXA13 and HOXB13 which are downregulated and predict poor patient survival likely possess tumor-suppressor activity and function by retro-inhibition of earlier HOX genes. Given HOX expression predicts survival and identifies SC phenotype, this indicates dysregulated HOX expression contributes to SC origin of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TretinoinNeoplastic Stem CellsColorectal NeoplasmsWnt Signaling PathwayGene Expression Regulation, NeoplasticHomeodomain ProteinsHumans

Stichwörter der Autor:innen

HOX genesWNT signalingcancer stem cellscolorectal cancerretinoic acid signaling

Substanzen

TretinoinHomeodomain Proteins

Autor:innen und Institutionen

  • Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute, Newark, DE 19713, United States.
  • Department of Biological Sciences, University of Delaware, Newark, DE 19716, United States.
  • Department of Mathematical Sciences, University of Delaware, Newark, DE 19716, United States.
  • Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, United States.

ORCID-Profile: Brian Osmond, Chi Zhang, Bruce M Boman

Förderung

  • The Lisa Dean Moseley Foundation
  • Cancer B*Ware Foundation
  • The Cawley Center for Translational Cancer Research Fund
  • The Carpenter Foundation
  • University of Delaware Department of Biological Sciences
  • INBRE NIH/NIGMS
  • CATX Inc.

Zitieren

APA

Osmond, B., Zhang, C., Kataboh, P. K., Facey, C. O. B., Opdenaker, L. M., & Boman, B. M. (2026). Imbalance in WNT: retinoic acid signaling dysregulates HOX gene expression: implications for cancer stem cell heterogeneity and CRC patient survival. Stem Cells Translational Medicine, 15(6). https://doi.org/10.1093/stcltm/szag043

Vancouver

Osmond B, Zhang C, Kataboh PK, Facey COB, Opdenaker LM, Boman BM. Imbalance in WNT: retinoic acid signaling dysregulates HOX gene expression: implications for cancer stem cell heterogeneity and CRC patient survival. Stem Cells Translational Medicine. 2026;15(6). doi:10.1093/stcltm/szag043

BibTeX
@article{Osmond2026,
  author = {Osmond, Brian and Zhang, Chi and Kataboh, Pascal K and Facey, Caroline O B and Opdenaker, Lynn M and Boman, Bruce M},
  title = {Imbalance in WNT: retinoic acid signaling dysregulates HOX gene expression: implications for cancer stem cell heterogeneity and CRC patient survival},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1093/stcltm/szag043}
}
Kostenlos starten →